S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
Log in

NASDAQ:RAPTRAPT Therapeutics Price Target & Analyst Ratings

$17.59
-0.10 (-0.57 %)
(As of 04/6/2020 03:02 PM ET)
Add
Compare
Today's Range
$17.53
Now: $17.59
$18.98
50-Day Range
$11.86
MA: $21.29
$31.30
52-Week Range
$10.52
Now: $17.59
$51.21
Volume252 shs
Average Volume76,359 shs
Market Capitalization$427.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

RAPT Therapeutics (NASDAQ:RAPT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for RAPT Therapeutics in the last 12 months. Their average twelve-month price target is $37.33, suggesting that the stock has a possible upside of 112.24%. The high price target for RAPT is $44.00 and the low price target for RAPT is $33.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $37.33$37.33$33.00N/A
Price Target Upside: 112.24% upside19.31% upside32.26% upsideN/A

RAPT Therapeutics (NASDAQ:RAPT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

RAPT Therapeutics (NASDAQ:RAPT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2020UBS GroupReiterated RatingPositive ➝ Buy$44.00Low
11/25/2019Wells Fargo & CoInitiated CoverageOutperform$33.00High
11/25/2019BMO Capital MarketsInitiated CoverageOutperform$35.00 ➝ $35.00High
(Data available from 4/6/2018 forward)
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Gap Down Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel